Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Fludarabine

   Jazz Pharmaceuticals Ireland Limited

   Acute Myeloid Leukemia, Adult

   phase 2 · small molecule · terminated

   1 trial →

2. Fluorodopa F 18

   BRIGHT MINDS BIOSCIENCES INC.

   Malignant Brain Neoplasm

   phase 2 · small molecule · active

   1 trial →

3. Fluorouracil

   United Therapeutics Europe Ltd

   Metastatic Biliary Tract Carcinoma

   phase 2 · small molecule · active

   1 trial →

4. Fluorouracil

   Arcus Biosciences

   Borderline Resectable Pancreatic Adenocarcinoma

   phase 2 · small molecule · active

   1 trial →

5. Fluorouracil

   United Therapeutics Europe Ltd

   Clinical Stage II Esophageal Adenocarcinoma AJCC v8

   phase 2 · small molecule · active

   1 trial →

6. Fluorouracile AHCL /ml for colorectal cancer

   Fondazione Telethon ETS

   colorectal cancer

   phase 2 · small molecule · active

   1 trial →

7. Folfox plus Bevacizumab and reolysin

   ONCOLYTICS BIOTECH INC

   Colorectal Cancer

   phase 2 · small molecule · completed

   1 trial →

8. Forodesine 200 mg

   Biocryst

   Cutaneous T-cell Lymphoma (CTCL),

   phase 2 · small molecule · completed

   1 trial →

9. Forxiga 10 mg film-coated tablets

   Fondazione Telethon ETS

   Chemotherapy-induced cardiotoxicity in breast cancer

   phase 2 · small molecule · active

   1 trial →

10. Fostamatinib Disodium

    RIGEL PHARMACEUTICALS INC

    T Cell Lymphoma

    phase 2 · small molecule · completed

    1 trial →

11. Fruquintinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 2 · small molecule · active

    1 trial →

12. Fruquintinib

    RenJi Hospital

    Stomach Neoplasms

    phase 2 · small molecule · active

    1 trial →

13. Fruquintinib

    Dai, Guanghai

    Colorectal Cancer Metastatic

    phase 2 · small molecule · active

    1 trial →

14. Fruquintinib Combined With Chemotherapy

    Takeda

    Metastatic Colorectal Cancer (CRC)

    phase 2 · small molecule · active

    1 trial →

15. Fulvestrant

    Syndax Pharmaceuticals

    Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

16. Fulvestrant

    United Therapeutics Europe Ltd

    Advanced Breast Cancer

    phase 2 · small molecule · active

    1 trial →

17. Fulvestrant

    ATOSSA THERAPEUTICS, INC.

    Female Breast Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

18. Fulvestrant with Enzalutamide

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

19. Functional Precision Oncology

    United Therapeutics Europe Ltd

    Breast Cancer Recurrent

    phase 2 · other · active

    1 trial →

20. Furmonertinib

    Peking University People's Hospital

    Adenocarcinoma of Lung

    phase 2 · small molecule · active

    1 trial →

21. Furmonertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Adenocarcinoma Stage III

    phase 2 · small molecule · active

    1 trial →

22. Furmonertinib

    The First People's Hospital of Lianyungang

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

23. Furmonertinib

    Shanghai University of Traditional Chinese Medicine

    Lung Adenocarcinoma Stage III

    phase 2 · small molecule · active

    1 trial →

24. Furmonertinib in combination with Anrotinib and chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

25. G100

    Lxo Ireland Designated Activity Company

    Follicular Low Grade Non-Hodgkin's Lymphoma

    phase 2 · small molecule · terminated

    1 trial →

26. GADOTERIC ACID, [18F]fludarabine

    Pari Pharma GmbH

    Patients with newly diagnosed primary central nervous system lymphoma naïve to surgery, radiotherapy or chemotherapy

    phase 2 · small molecule · active

    1 trial →

27. GC4419

    Galera Therapeutics

    Pancreatic Cancer

    phase 2 · small molecule · completed

    1 trial →

28. GCT1015-05

    Genmab A/S

    Recurrent or stage IVB cervical cancer

    phase 2 · small molecule · active

    1 trial →

29. GCT1042-01

    Genmab A/S

    Malignant solid tumors: Patients with relapsed or refractory, advanced and/or metastatic melanoma, Non-Small Cell Lung Cancer (NSCLC), Head and neck squamous cell carcinoma (HNSCC), Panctreatic ductal adenocarcinoma (PDAC) or Colorectal Cancer (CRC).

    phase 2 · small molecule · active

    1 trial →

30. GCT1046-01

    Genmab A/S

    Malignant solid tumors: endometrial carcinoma (EC), urothelial carcinoma (UC), triple-negative breast cancer (TNBC), squamous cell carcinoma of the head and neck (SCCHN), or cervical cancer.

    phase 2 · small molecule · active

    1 trial →

31. GCT1046-04

    Genmab A/S

    Malignant Solid Tumors - Non Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

32. GCT1046-07

    Genmab A/S

    Cutaneous Melanoma, Relapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID), Metastatic Cutaneous Melanoma (Stage IV)

    phase 2 · small molecule · active

    1 trial →

33. GCT1055-01

    Genmab A/S

    Malignant Solid Tumors

    phase 2 · small molecule · active

    1 trial →

34. GCT3013-01

    Genmab A/S

    Lymphoma of B-cell origin

    phase 2 · small molecule · active

    1 trial →

35. GCT3013-02

    Genmab A/S

    Lymphoma of B-cell origin

    phase 2 · small molecule · active

    1 trial →

36. GCT3013-03

    Genmab A/S

    Chronic Lymphocytic Leukemia

    phase 2 · small molecule · active

    1 trial →

37. GCT3014-01

    Genmab A/S

    Relapsed or Refractory Multiple Myeloma (RRMM) Diffuse Large B Cell Lymphoma (DLBCL) Acute Myeloid Leukemia (AML)

    phase 2 · small molecule · active

    1 trial →

38. GDX012

    Takeda

    Leukemia

    phase 2 · small molecule · terminated

    1 trial →

39. GEICAM/2014-12

    Ningbo Cancer Hospital

    Metastatic breast cancer

    phase 2 · small molecule · active

    1 trial →

40. GEICAM/2020-08

    Ningbo Cancer Hospital

    Non-resectable locally advanced or metastatic HER2-positive breast cancer

    phase 2 · small molecule · active

    1 trial →

41. GEM 2301

    Disc Medicine

    Melanoma

    phase 2 · small molecule · active

    1 trial →

42. GEM 2303

    Disc Medicine

    Advanced Melanoma

    phase 2 · small molecule · active

    1 trial →

43. GEM-2101

    Disc Medicine

    Uveal melanoma

    phase 2 · small molecule · active

    1 trial →

44. GEMCAD - 2103//MO4

    Disc Medicine

    Squamous cell carcinoma of the anal canal

    phase 2 · small molecule · active

    1 trial →

45. GEMCAD 2102

    Disc Medicine

    Colorectal cancer

    phase 2 · small molecule · active

    1 trial →

46. GEMCAD-1802

    Disc Medicine

    Colorectal cancer and metastatic disease limited to the liver with bad prognosis.

    phase 2 · small molecule · active

    1 trial →

47. GEMCITABINE

    Wuhan Createrna Science and Technology Co., Ltd

    Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cell carcinoma

    phase 2 · small molecule · active

    1 trial →

48. GEN1042 DP, PEMBROLIZUMAB

    Genmab A/S

    Metastatic Solid Malignant tumors

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions